Henri Bergeron – författare

When does epidemic disease disrupt society to the point where it becomes a political crisis? In the early 1980s, almost unnoticed in the larger drama that was AIDS, over half of hemophiliacs and a large number of blood transfusion recipients were infected with toxic blood contaminated with HIV. The French public's "discovery" of this catastrophe in the early 1990s created a transformative political crisis; this same discovery in the United States went largely unnoticed. In The Social Production of Crisis, Constance A. Nathanson and Henri Bergeron focus on a profoundly troubling story to present a detailed case comparative analysis not only of the catastrophe itself and its multiple retrospective interpretations but also of its intimate connection to the history and organization of blood as a consumer product in each country. They draw on secondary sources, archival research, and interviews with key players to provide a historical, political, and social reconstruction of the HIV contamination of the blood supply to answer the question of how and why disease morphed into crisis in France and not in the United States. They also raise questions about the curious immunity to human suffering as a policy engine in the United States, about the often reiterated weakness of civil society in France, and about theorizing alternative epidemic trajectories. Investigating a series of morally shocking events, this book develops a sociological theory of how political crises are socially produced and raises questions about disease policy and politics in the US and France.

The drug control regime established by the international community has not succeeded in curbing either the demand for, or the offer of, narcotics. But, despite a series of developments in the Americas – including the legalisation of cannabis in Uruguay and in several states in the United States of America – there is still little support in Europe for repealing drug-prohibition laws. Nevertheless, a gradual policy convergence reveals the emergence of a European model favouring public-health strategies over a strictly penal approach to combatting drugs, while growing transnational support for legalisation indicates the persistence of an alternative paradigm for drug policy. This book examines the various influences on drug policies in Europe, as grassroots movements, NGO networks, private foundations and academic research centres increasingly confront the prevailing discourses of drug prohibition. Pursuing an interdisciplinary approach and bringing together legal scholars, social scientists and practitioners, it provides a comprehensive and critical assessment of drug policy reform in Europe.

The drug control regime established by the international community has not succeeded in curbing either the demand for, or the offer of, narcotics. But, despite a series of developments in the Americas – including the legalisation of cannabis in Uruguay and in several states in the United States of America – there is still little support in Europe for repealing drug-prohibition laws. Nevertheless, a gradual policy convergence reveals the emergence of a European model favouring public-health strategies over a strictly penal approach to combatting drugs, while growing transnational support for legalisation indicates the persistence of an alternative paradigm for drug policy. This book examines the various influences on drug policies in Europe, as grassroots movements, NGO networks, private foundations and academic research centres increasingly confront the prevailing discourses of drug prohibition. Pursuing an interdisciplinary approach and bringing together legal scholars, social scientists and practitioners, it provides a comprehensive and critical assessment of drug policy reform in Europe.